Clinical trials
Peripheral Vascular Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 6 |
| Barnsley Hospital | 2 |
| Hull University Teaching Hospitals NHS Trust | 2 |
| Imperial College Healthcare NHS Trust | 2 |
| Tanabe Pharma Corporation | 2 |
| Biopure Corporation | 1 |
| C. R. Bard | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Ethicon, Inc. | 1 |
| Genzyme, a Sanofi Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Vascular Diseases | 24 |
| Peripheral Arterial Disease | 11 |
| Intermittent Claudication | 8 |
| Chronic Limb-Threatening Ischemia | 5 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Diabetic Foot | 2 |
| Stroke | 2 |
| Atherosclerosis | 1 |
| Coronary Artery Disease | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.